Starling Oncology, Inc. Lease, Cost
Starling Oncology, Inc. (DFPH) reported Lease, Cost of $10.52 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-03-12
- Starling Oncology, Inc. lease, cost for fiscal 2025 was $10.52M, a 2.58% increase from fiscal 2024.
- Starling Oncology, Inc. lease, cost for fiscal 2024 was $10.25M, a 15.13% increase from fiscal 2023.
- Starling Oncology, Inc. lease, cost for fiscal 2023 was $8.90M, a 20.32% increase from fiscal 2022.
- Starling Oncology, Inc. lease, cost for fiscal 2022 was $7.40M.
| Period end | Lease, Cost 12 month |
|---|---|
| 2025-12-31 | $10.52M 10-K · filed 2026-03-12 |
| 2024-12-31 | $10.25M 10-K · filed 2026-03-12 |
| 2023-12-31 | $8.90M 10-K · filed 2025-03-26 |
| 2022-12-31 | $7.40M 10-K · filed 2024-03-28 |